Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 601

1.

The Predictive Value of Head Circumference Growth during the First Year of Life on Early Child Traits.

Dupont C, Castellanos-Ryan N, Séguin JR, Muckle G, Simard MN, Shapiro GD, Herba CM, Fraser WD, Lippé S.

Sci Rep. 2018 Jun 29;8(1):9828. doi: 10.1038/s41598-018-28165-8.

2.

Adverse birth outcomes in relation to maternal marital and cohabitation status in Canada.

Shapiro GD, Bushnik T, Wilkins R, Kramer MS, Kaufman JS, Sheppard AJ, Yang S.

Ann Epidemiol. 2018 May 22. pii: S1047-2797(17)31164-X. doi: 10.1016/j.annepidem.2018.05.001. [Epub ahead of print]

PMID:
29937402
3.

The Development and Validity of the Adult Burn Outcome Questionnaire Short Form.

Chen L, Lee AF, Shapiro GD, Goverman J, Faoro N, Schneider JC, Kazis LE, Ryan CM.

J Burn Care Res. 2017 Dec 6. doi: 10.1093/jbcr/irx043. [Epub ahead of print]

PMID:
29931275
4.

Recent Advances and Future of Gene Therapy for Bone Regeneration.

Shapiro G, Lieber R, Gazit D, Pelled G.

Curr Osteoporos Rep. 2018 Jun 16. doi: 10.1007/s11914-018-0459-3. [Epub ahead of print] Review.

PMID:
29909597
5.

Real-time genomic characterization of advanced pancreatic cancer to enable precision medicine.

Aguirre AJ, Nowak JA, Camarda ND, Moffitt RA, Ghazani AA, Hazar-Rethinam M, Raghavan S, Kim J, Brais LK, Ragon D, Welch MW, Reilly E, McCabe D, Marini L, Anderka K, Helvie K, Oliver N, Babic A, Da Silva A, Nadres B, Van Seventer EE, Shahzade HA, St Pierre JP, Burke KP, Clancy TE, Cleary JM, Doyle LA, Jajoo K, McCleary NJ, Meyerhardt JA, Murphy JE, Ng K, Patel AK, Perez K, Rosenthal MH, Rubinson DA, Ryou M, Shapiro GI, Sicinska E, Silverman SG, Nagy RJ, Lanman RB, Knoerzer D, Welsch DJ, Yurgelun MB, Fuchs CS, Garraway LA, Getz G, Hornick JL, Johnson BE, Kulke MH, Mayer RJ, Miller JW, Shyn PB, Tuveson DA, Wagle N, Yeh JJ, Hahn WC, Corcoran RB, Carter SL, Wolpin BM.

Cancer Discov. 2018 Jun 14. pii: CD-18-0275. doi: 10.1158/2159-8290.CD-18-0275. [Epub ahead of print]

PMID:
29903880
6.

The Effect of Facial Burns on Long-Term Outcomes in Young Adults: A 5-Year Study.

Ryan CM, Lee A, Stoddard FJ Jr, Li NC, Schneider JC, Shapiro GD, Griggs CL, Wang C, Palmieri T, Meyer WJ 3rd, Pidcock FS, Reilly D, Sheridan RL, Kazis LE, Tompkins RG; Multi-Center Benchmarking Study Group.

J Burn Care Res. 2018 Jun 13;39(4):497-506. doi: 10.1093/jbcr/irx006.

PMID:
29901795
7.

An adaptive grid to improve the efficiency and accuracy of modelling underwater noise from shipping.

Trigg LE, Chen F, Shapiro GI, Ingram SN, Embling CB.

Mar Pollut Bull. 2018 Jun;131(Pt A):589-601. doi: 10.1016/j.marpolbul.2018.04.034. Epub 2018 May 3.

PMID:
29886986
8.

Maternal and cord blood manganese (Mn) levels and birth weight: The MIREC birth cohort study.

Ashley-Martin J, Dodds L, Arbuckle TE, Ettinger AS, Shapiro GD, Fisher M, Monnier P, Morisset AS, Fraser WD, Bouchard MF.

Int J Hyg Environ Health. 2018 Jul;221(6):876-882. doi: 10.1016/j.ijheh.2018.05.015. Epub 2018 Jun 7.

9.

Pharmacokinetic Study of Rucaparib in Patients With Advanced Solid Tumors.

Shapiro GI, Kristeleit RS, Burris HA, LoRusso P, Patel MR, Drew Y, Giordano H, Maloney L, Watkins S, Goble S, Jaw-Tsai S, Xiao JJ.

Clin Pharmacol Drug Dev. 2018 May 25. doi: 10.1002/cpdd.575. [Epub ahead of print]

PMID:
29799676
10.

Phase I study of the checkpoint kinase 1 inhibitor GDC-0575 in combination with gemcitabine in patients with refractory solid tumors.

Italiano A, Infante JR, Shapiro GI, Moore KN, LoRusso PM, Hamilton E, Cousin S, Toulmonde M, Postel-Vinay S, Tolaney S, Blackwood EM, Mahrus S, Peale FV, Lu X, Moein A, Epler J, DuPree K, Tagen M, Murray ER, Schutzman JL, Lauchle JO, Hollebecque A, Soria JC.

Ann Oncol. 2018 Feb 23. doi: 10.1093/annonc/mdy076. [Epub ahead of print]

PMID:
29788155
11.

Ultrasound-Mediated Gene Delivery Enhances Tendon Allograft Integration in Mini-Pig Ligament Reconstruction.

Bez M, Kremen TJ, Tawackoli W, Avalos P, Sheyn D, Shapiro G, Giaconi JC, Ben David S, Snedeker JG, Gazit Z, Ferrara KW, Gazit D, Pelled G.

Mol Ther. 2018 Jul 5;26(7):1746-1755. doi: 10.1016/j.ymthe.2018.04.020. Epub 2018 Apr 26.

PMID:
29784586
12.

The Associations of Gender With Social Participation of Burn Survivors: A Life Impact Burn Recovery Evaluation Profile Study.

Levi B, Kraft CT, Shapiro GD, Trinh NT, Dore EC, Jeng J, Lee AF, Acton A, Marino M, Jette A, Armstrong EA, Schneider JC, Kazis LE, Ryan CM.

J Burn Care Res. 2018 May 4. doi: 10.1093/jbcr/iry007. [Epub ahead of print]

PMID:
29733365
13.

Serum Obestatin: A Biomarker of Cardiovascular and All-Cause Mortality in Hemodialysis Patients.

Beberashvili I, Katkov A, Sinuani I, Azar A, Shapiro G, Feldman L, Gorelik O, Stav K, Efrati S.

Am J Nephrol. 2018;47(4):254-265. doi: 10.1159/000488285. Epub 2018 Apr 25.

PMID:
29694945
14.

Fatal Wounding Pattern and Causes of Potentially Preventable Death Following the Pulse Night Club Shooting Event.

Smith ER, Shapiro G, Sarani B.

Prehosp Emerg Care. 2018 Apr 25:1-7. doi: 10.1080/10903127.2018.1459980. [Epub ahead of print]

PMID:
29693490
15.

RAS-MAPK Reactivation Facilitates Acquired Resistance in FGFR1-Amplified Lung Cancer and Underlies a Rationale for Upfront FGFR-MEK Blockade.

Bockorny B, Rusan M, Chen W, Liao RG, Li Y, Piccioni F, Wang J, Tan L, Thorner AR, Li T, Zhang Y, Miao C, Ovesen T, Shapiro GI, Kwiatkowski DJ, Gray NS, Meyerson M, Hammerman PS, Bass AJ.

Mol Cancer Ther. 2018 Jul;17(7):1526-1539. doi: 10.1158/1535-7163.MCT-17-0464. Epub 2018 Apr 13.

PMID:
29654068
16.

Phase I Trial of a Tablet Formulation of Pilaralisib, a Pan-Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors.

Edelman G, Rodon J, Lager J, Castell C, Jiang J, Van Allen EM, Wagle N, Lindeman NI, Sholl LM, Shapiro GI.

Oncologist. 2018 Apr;23(4):401-e38. doi: 10.1634/theoncologist.2017-0691. Epub 2018 Mar 28.

17.

Proceedings from the 2017 Mid-Year Meeting of the Committee for Tactical Emergency Casualty Care (C-TECC) and Committee Updates.

Hartford B, Shapiro G, Marino MJ, Smith R, Tang N.

J Spec Oper Med. Spring 2018;18(1):160-161. No abstract available.

PMID:
29533454
18.

A First-in-Human Phase I Study of OPB-111077, a Small-Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients with Advanced Cancers.

Tolcher A, Flaherty K, Shapiro GI, Berlin J, Witzig T, Habermann T, Bullock A, Rock E, Elekes A, Lin C, Kostic D, Ohi N, Rasco D, Papadopoulos KP, Patnaik A, Smith L, Cote GM.

Oncologist. 2018 Jun;23(6):658-e72. doi: 10.1634/theoncologist.2017-0325. Epub 2018 Mar 6.

PMID:
29511132
19.

Cabozantinib in Patients with Advanced Merkel Cell Carcinoma.

Rabinowits G, Lezcano C, Catalano PJ, McHugh P, Becker H, Reilly MM, Huang J, Tyagi A, Thakuria M, Bresler SC, Sholl LM, Shapiro GI, Haddad R, DeCaprio JA.

Oncologist. 2018 Feb 14. pii: theoncologist.2017-0552. doi: 10.1634/theoncologist.2017-0552. [Epub ahead of print]

PMID:
29445030
20.

HER kinase inhibition in patients with HER2- and HER3-mutant cancers.

Hyman DM, Piha-Paul SA, Won H, Rodon J, Saura C, Shapiro GI, Juric D, Quinn DI, Moreno V, Doger B, Mayer IA, Boni V, Calvo E, Loi S, Lockhart AC, Erinjeri JP, Scaltriti M, Ulaner GA, Patel J, Tang J, Beer H, Selcuklu SD, Hanrahan AJ, Bouvier N, Melcer M, Murali R, Schram AM, Smyth LM, Jhaveri K, Li BT, Drilon A, Harding JJ, Iyer G, Taylor BS, Berger MF, Cutler RE Jr, Xu F, Butturini A, Eli LD, Mann G, Farrell C, Lalani AS, Bryce RP, Arteaga CL, Meric-Bernstam F, Baselga J, Solit DB.

Nature. 2018 Feb 8;554(7691):189-194. doi: 10.1038/nature25475. Epub 2018 Jan 31.

PMID:
29420467
21.

Age modifies the association between serum obestatin, appetite and nutritional status in maintenance hemodialysis patients.

Katkov A, Sinuani I, Azar A, Shapiro G, Efrati S, Beberashvili I.

Eur J Clin Nutr. 2018 Jul;72(7):1007-1018. doi: 10.1038/s41430-018-0087-0. Epub 2018 Jan 23.

PMID:
29362457
22.

Knowledge and Attitudes of General Practitioners and Sexual Health Care Professionals Regarding Human Papillomavirus Vaccination for Young Men Who Have Sex with Men.

Merriel SWD, Flannagan C, Kesten JM, Shapiro GK, Nadarzynski T, Prue G.

Int J Environ Res Public Health. 2018 Jan 18;15(1). pii: E151. doi: 10.3390/ijerph15010151.

23.

The vaccine hesitancy scale: Psychometric properties and validation.

Shapiro GK, Tatar O, Dube E, Amsel R, Knauper B, Naz A, Perez S, Rosberger Z.

Vaccine. 2018 Jan 29;36(5):660-667. doi: 10.1016/j.vaccine.2017.12.043. Epub 2017 Dec 27.

PMID:
29289384
24.

Identification of a CARM1 Inhibitor with Potent In Vitro and In Vivo Activity in Preclinical Models of Multiple Myeloma.

Drew AE, Moradei O, Jacques SL, Rioux N, Boriack-Sjodin AP, Allain C, Scott MP, Jin L, Raimondi A, Handler JL, Ott HM, Kruger RG, McCabe MT, Sneeringer C, Riera T, Shapiro G, Waters NJ, Mitchell LH, Duncan KW, Moyer MP, Copeland RA, Smith J, Chesworth R, Ribich SA.

Sci Rep. 2017 Dec 21;7(1):17993. doi: 10.1038/s41598-017-18446-z.

25.

Ketamine in the Prehospital Environment: A National Survey of Paramedics in the United States.

Buckland DM, Crowe RP, Cash RE, Gondek S, Maluso P, Sirajuddin S, Smith ER, Dangerfield P, Shapiro G, Wanka C, Panchal AR, Sarani B.

Prehosp Disaster Med. 2018 Feb;33(1):23-28. doi: 10.1017/S1049023X17007142. Epub 2017 Dec 21.

PMID:
29265995
26.

First-in-Class ERK1/2 Inhibitor Ulixertinib (BVD-523) in Patients with MAPK Mutant Advanced Solid Tumors: Results of a Phase I Dose-Escalation and Expansion Study.

Sullivan RJ, Infante JR, Janku F, Wong DJL, Sosman JA, Keedy V, Patel MR, Shapiro GI, Mier JW, Tolcher AW, Wang-Gillam A, Sznol M, Flaherty K, Buchbinder E, Carvajal RD, Varghese AM, Lacouture ME, Ribas A, Patel SP, DeCrescenzo GA, Emery CM, Groover AL, Saha S, Varterasian M, Welsch DJ, Hyman DM, Li BT.

Cancer Discov. 2018 Feb;8(2):184-195. doi: 10.1158/2159-8290.CD-17-1119. Epub 2017 Dec 15.

PMID:
29247021
27.

Associations between maternal triclosan concentrations in early pregnancy and gestational diabetes mellitus, impaired glucose tolerance, gestational weight gain and fetal markers of metabolic function.

Shapiro GD, Arbuckle TE, Ashley-Martin J, Fraser WD, Fisher M, Bouchard MF, Monnier P, Morisset AS, Ettinger AS, Dodds L.

Environ Res. 2018 Feb;161:554-561. doi: 10.1016/j.envres.2017.12.001.

28.

Genomic Biomarkers Predicting Response to Selective CDK4/6 Inhibition: Progress in an Elusive Search.

Shapiro GI.

Cancer Cell. 2017 Dec 11;32(6):721-723. doi: 10.1016/j.ccell.2017.11.013.

PMID:
29232548
29.

Correlates of Tinder Use and Risky Sexual Behaviors in Young Adults.

Shapiro GK, Tatar O, Sutton A, Fisher W, Naz A, Perez S, Rosberger Z.

Cyberpsychol Behav Soc Netw. 2017 Dec;20(12):727-734. doi: 10.1089/cyber.2017.0279. Epub 2017 Dec 6.

PMID:
29211500
30.

Sensitizing HR-proficient cancers to PARP inhibitors.

Lim E, Johnson SF, Geyer M, Serra V, Shapiro GI.

Mol Cell Oncol. 2017 Mar 3;4(6):e1299272. doi: 10.1080/23723556.2017.1299272. eCollection 2017. No abstract available.

31.

Parents' involvement in the human papillomavirus vaccination decision for their sons.

Perez S, Restle H, Naz A, Tatar O, Shapiro GK, Rosberger Z.

Sex Reprod Healthc. 2017 Dec;14:33-39. doi: 10.1016/j.srhc.2017.08.005. Epub 2017 Aug 24.

PMID:
29195632
32.

Impact of Work-Related Burn Injury on Social Reintegration Outcomes: A Life Impact Burn Recovery Evaluation (LIBRE) Study.

Schneider JC, Shie VL, Espinoza LF, Shapiro GD, Lee A, Acton A, Marino M, Jette A, Kazis LE, Ryan CM; LIBRE Advisory Board.

Arch Phys Med Rehabil. 2017 Nov 26. pii: S0003-9993(17)31383-7. doi: 10.1016/j.apmr.2017.10.022. [Epub ahead of print]

PMID:
29183751
33.

Psychosocial correlates of HPV vaccine acceptability in college males: A cross-sectional exploratory study.

Tatar O, Perez S, Naz A, Shapiro GK, Rosberger Z.

Papillomavirus Res. 2017 Dec;4:99-107. doi: 10.1016/j.pvr.2017.11.001. Epub 2017 Nov 8.

34.

U.S. pregnant women's knowledge and attitudes about behavioral strategies and vaccines to prevent Zika acquisition.

Fraiz LD, de Roche A, Mauro C, Catallozzi M, Zimet GD, Shapiro GK, Rosenthal SL.

Vaccine. 2018 Jan 2;36(1):165-169. doi: 10.1016/j.vaccine.2017.11.021. Epub 2017 Nov 20.

PMID:
29157958
35.

Development of clinical process measures for pediatric burn care: Understanding variation in practice patterns.

Kazis LE, Sheridan RL, Shapiro GD, Lee AF, Liang MH, Ryan CM, Schneider JC, Lydon M, Soley-Bori M, Sonis LA, Dore EC, Palmieri T, Herndon D, Meyer W, Warner P, Kagan R, Stoddard FJ, Murphy M, Tompkins RG.

J Trauma Acute Care Surg. 2018 Apr;84(4):620-627. doi: 10.1097/TA.0000000000001737.

PMID:
29140950
36.

Birth outcomes among First Nations, Inuit and Métis populations.

Sheppard AJ, Shapiro GD, Bushnik T, Wilkins R, Perry S, Kaufman JS, Kramer MS, Yang S.

Health Rep. 2017 Nov 15;28(11):11-16.

37.

CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation.

Deng J, Wang ES, Jenkins RW, Li S, Dries R, Yates K, Chhabra S, Huang W, Liu H, Aref AR, Ivanova E, Paweletz CP, Bowden M, Zhou CW, Herter-Sprie GS, Sorrentino JA, Bisi JE, Lizotte PH, Merlino AA, Quinn MM, Bufe LE, Yang A, Zhang Y, Zhang H, Gao P, Chen T, Cavanaugh ME, Rode AJ, Haines E, Roberts PJ, Strum JC, Richards WG, Lorch JH, Parangi S, Gunda V, Boland GM, Bueno R, Palakurthi S, Freeman GJ, Ritz J, Haining WN, Sharpless NE, Arthanari H, Shapiro GI, Barbie DA, Gray NS, Wong KK.

Cancer Discov. 2018 Feb;8(2):216-233. doi: 10.1158/2159-8290.CD-17-0915. Epub 2017 Nov 3.

PMID:
29101163
38.

Long-Term Social Reintegration Outcomes for Burn Survivors With and Without Peer Support Attendance: A Life Impact Burn Recovery Evaluation (LIBRE) Study.

Grieve B, Shapiro GD, Wibbenmeyer L, Acton A, Lee A, Marino M, Jette A, Schneider JC, Kazis LE, Ryan CM; LIBRE Advisory Board.

Arch Phys Med Rehabil. 2017 Oct 31. pii: S0003-9993(17)31328-X. doi: 10.1016/j.apmr.2017.10.007. [Epub ahead of print]

PMID:
29097179
39.

Validation of the vaccine conspiracy beliefs scale.

Shapiro GK, Holding A, Perez S, Amsel R, Rosberger Z.

Papillomavirus Res. 2016 Dec;2:167-172. doi: 10.1016/j.pvr.2016.09.001. Epub 2016 Sep 30.

40.

Phase II randomised discontinuation trial of cabozantinib in patients with advanced solid tumours.

Schöffski P, Gordon M, Smith DC, Kurzrock R, Daud A, Vogelzang NJ, Lee Y, Scheffold C, Shapiro GI.

Eur J Cancer. 2017 Nov;86:296-304. doi: 10.1016/j.ejca.2017.09.011. Epub 2017 Oct 20.

41.

Co-responding police-mental health programmes: Service user experiences and outcomes in a large urban centre.

Lamanna D, Shapiro GK, Kirst M, Matheson FI, Nakhost A, Stergiopoulos V.

Int J Ment Health Nurs. 2018 Apr;27(2):891-900. doi: 10.1111/inm.12384. Epub 2017 Oct 17.

PMID:
29044920
42.

Investigating Canadian parents' HPV vaccine knowledge, attitudes and behaviour: a study protocol for a longitudinal national online survey.

Shapiro GK, Perez S, Naz A, Tatar O, Guichon JR, Amsel R, Zimet GD, Rosberger Z.

BMJ Open. 2017 Oct 11;7(10):e017814. doi: 10.1136/bmjopen-2017-017814.

43.

Semiautomated Longitudinal Microcomputed Tomography-based Quantitative Structural Analysis of a Nude Rat Osteoporosis-related Vertebral Fracture Model.

Shapiro G, Bez M, Tawackoli W, Gazit Z, Gazit D, Pelled G.

J Vis Exp. 2017 Sep 28;(127). doi: 10.3791/55928.

PMID:
28994771
44.

Comparing human papillomavirus vaccine concerns on Twitter: a cross-sectional study of users in Australia, Canada and the UK.

Shapiro GK, Surian D, Dunn AG, Perry R, Kelaher M.

BMJ Open. 2017 Oct 5;7(10):e016869. doi: 10.1136/bmjopen-2017-016869.

45.

First-in-human trial of the PI3Kβ-selective inhibitor SAR260301 in patients with advanced solid tumors.

Bédard PL, Davies MA, Kopetz S, Juric D, Shapiro GI, Luke JJ, Spreafico A, Wu B, Castell C, Gomez C, Cartot-Cotton S, Mazuir F, Dubar M, Micallef S, Demers B, Flaherty KT.

Cancer. 2018 Jan 15;124(2):315-324. doi: 10.1002/cncr.31044. Epub 2017 Oct 4.

PMID:
28976556
46.

Canadian school-based HPV vaccine programs and policy considerations.

Shapiro GK, Guichon J, Kelaher M.

Vaccine. 2017 Oct 9;35(42):5700-5707. doi: 10.1016/j.vaccine.2017.07.079.

PMID:
28893472
47.

Phase 1 safety, pharmacokinetic and pharmacodynamic study of the cyclin-dependent kinase inhibitor dinaciclib administered every three weeks in patients with advanced malignancies.

Mita MM, Mita AC, Moseley JL, Poon J, Small KA, Jou YM, Kirschmeier P, Zhang D, Zhu Y, Statkevich P, Sankhala KK, Sarantopoulos J, Cleary JM, Chirieac LR, Rodig SJ, Bannerji R, Shapiro GI.

Br J Cancer. 2017 Oct 24;117(9):1258-1268. doi: 10.1038/bjc.2017.288. Epub 2017 Aug 31.

PMID:
28859059
48.

Synergy of WEE1 and mTOR Inhibition in Mutant KRAS-Driven Lung Cancers.

Hai J, Liu S, Bufe L, Do K, Chen T, Wang X, Ng C, Li S, Tsao MS, Shapiro GI, Wong KK.

Clin Cancer Res. 2017 Nov 15;23(22):6993-7005. doi: 10.1158/1078-0432.CCR-17-1098. Epub 2017 Aug 18.

PMID:
28821559
49.

Primed polymorphonuclear leukocytes from hemodialysis patients enhance monocyte transendothelial migration.

Kliger E, Kristal B, Shapiro G, Chezar J, Sela S.

Am J Physiol Heart Circ Physiol. 2017 Nov 1;313(5):H974-H987. doi: 10.1152/ajpheart.00122.2017. Epub 2017 Aug 4.

PMID:
28778910
50.

Glesatinib Exhibits Antitumor Activity in Lung Cancer Models and Patients Harboring MET Exon 14 Mutations and Overcomes Mutation-mediated Resistance to Type I MET Inhibitors in Nonclinical Models.

Engstrom LD, Aranda R, Lee M, Tovar EA, Essenburg CJ, Madaj Z, Chiang H, Briere D, Hallin J, Lopez-Casas PP, Baños N, Menendez C, Hidalgo M, Tassell V, Chao R, Chudova DI, Lanman RB, Olson P, Bazhenova L, Patel SP, Graveel C, Nishino M, Shapiro GI, Peled N, Awad MM, Jänne PA, Christensen JG.

Clin Cancer Res. 2017 Nov 1;23(21):6661-6672. doi: 10.1158/1078-0432.CCR-17-1192. Epub 2017 Aug 1.

PMID:
28765324

Supplemental Content

Loading ...
Support Center